TXA-709

N/A

Report date: 2023/02/26 15:45:20
NMEQIDP

Base Information

Drug NameTXA-709
Drug Alias NameTXA-709
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial FtsZ proteins inhibitors
TargetsBacterial FtsZ proteins
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTaxis Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesTaxis Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsStaphylococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A